Rchr
J-GLOBAL ID:200901072427460699   Update date: Sep. 19, 2024

masataka okamoto

オカモト マサタカ | masataka okamoto
Affiliation and department:
Research field  (1): Hematology and oncology
Research keywords  (4): follicular lymphoma ,  mantle-cell ymphoma ,  low grade B-cell lymphoma ,  malignant lymphoma
Papers (86):
  • Chisako Iriyama, Kenichiro Murate, Sachiko Iba, Akinao Okamoto, Naoe Goto, Hideyuki Yamamoto, Toshiharu Kato, Keichiro Mihara, Takahiko Miyama, Keiko Hattori, et al. Utility of cerebrospinal fluid liquid biopsy in distinguishing CNS lymphoma from cerebrospinal infectious/demyelinating diseases. Cancer medicine. 2023
  • Hideyuki Yamamoto, Yuki Mizutani, Chisako Iriyama, Naoe Goto, Akinao Okamoto, Toshiharu Kato, Chiyo Shintani, Naoki Yamamoto, Takahiko Miyama, Keichiro Mihara, et al. Acute fulminant intravascular hemolysis induced by Clostridium perfringens in a symptomatic multiple myeloma patient under immuno-chemotherapy. Annals of hematology. 2022. 101. 12. 2813-2815
  • Akinao Okamoto, Hidetsugu Fujigaki, Chisako Iriyama, Naoe Goto, Hideyuki Yamamoto, Keichiro Mihara, Yoko Inaguma, Yasuo Miura, Katsuya Furukawa, Yukiya Yamamoto, et al. CD19-positive lymphocyte count is critical for acquisition of anti-SARS-CoV-2 IgG after vaccination in B-cell lymphoma. Blood advances. 2022. 6. 11. 3230-3233
  • Shinichi Makita, Shigeru Kusumoto, Akiko Miyagi Maeshima, Hiroya Hashimoto, Hideki Tsujimura, Toshiki Uchida, Hiroaki Inoue, Eiichi Ohtsuka, Mitsutoshi Kurosawa, Nobuyuki Takayama, et al. Clinical Outcomes of Elderly Patients with Advanced-Stage Classic Hodgkin Lymphoma Who Received an ABVD Regimen: A Multi-Center Retrospective Study in Japan (HORIZON study). BLOOD. 2021. 138
  • Chisako Iriyama, Kenichiro Murate, Sachiko Iba, Akinao Okamoto, Hideyuki Yamamoto, Ayana Kanbara, Akane Sato, Emiko Iwata, Ryuta Yamada, Masataka Okamoto, et al. Detection of circulating tumor DNA in cerebrospinal fluid prior to diagnosis of spinal cord lymphoma by flow cytometric and cytologic analyses. Annals of Hematology. 2021
more...
MISC (196):
  • A case of CSF3R mutation-positive myeloproliferative neoplasm with IgM-high MYD88 mutation-positive lymphoproliferative neoplasm in which the proportion of clones present changed during the use of ruxolitinib. The Journal of the Japanese Society for Lymphoreticular Tissue Research. 2024. 64. 110-110
  • Masataka Okamoto. Extranodal mucosa-associated lymphoid tissue marginal zone lymphoma (MALT lymphoma). 2024. 253-259
  • -. Japanese Journal of Clinical Hematology. 2023. 64. 10. 674-674
  • A multicenter observational study on factors contributing to the severity of COVID-19 in patients with hematological diseases. Japanese Journal of Clinical Hematology. 2023. 64. 10. 1491-1491
  • 後藤尚絵, 加藤駿晴, 山本秀行, 岡本晃直, 入山智沙子, 岡本昌隆, 冨田 章裕. 当院における自己末梢血幹細胞移植適応未治療進行期マントル細胞リンパ腫患者4例におけるBendamustine,高用量Cytarabineを用いた寛解導入療法の後方視的検討. 日本リンパ網内系学会会誌. 2023. 63. 123-123
more...
Books (48):
  • Blood Syndromes (3rd ed.)
    2024
  • Visual Clinical Hematology (Revised 4th Edition)
    2021
  • 造血器腫瘍学(第2版)-基礎と臨床の最新研究動向-
    日本臨牀社 2020
  • 造血器腫瘍診療ガイドライン 2018年版補訂版 [2020年4月]
    金原出版 2020 ISBN:9784307101622
  • Malignant Lymphoma Treatment Manual
    2020
more...
Lectures and oral presentations  (55):
  • Treatment outcomes of dose-adjusted (DA)-EPOCH-R combined with high-dose methotrexate in patients with CD5-positive diffuse large B-cell lymphoma: a multi-institutional observational study
    (The 66th ASH Annual Meeting and Exposition 2023)
  • Five-year results of a phase 2 study of CNS-oriented therapy with R-CHOP for untreated intravascular large B-cell lymphoma: Final analysis of the PRIMEUR-IVL study
    (17th International Conference on Malignant Lymphoma 2023)
  • Prospective Study of the Usefulness of Liquid Biopsy in Patients with Unknown Fever Suspected of Malignant Lymphoma -LYLY4 Study-
    (64th American Society of Hematology (ASH) Annual Meeting & Exposition 2022)
  • Clinical outcomes of elderly patients with advanced-stage classic Hodgkin lymphoma who received an ABVD regimen: a multi-center retrospective study in Japan (HORIZON study
    (63th American Society of Hematology (ASH) Annual Meeting & Exposition 2021)
  • -
    (The 61st Annual Meeting of the Japanese Society for Lymphoreticular Tissue Research 2021)
more...
Education (1):
  • 1987 - 現在 藤田保健衛生大学 大学院医学研究科 病態血液学科
Professional career (1):
  • 博士(医学) (藤田保健衛生大学)
Work history (7):
  • 2020/04 - 現在 Fujita Health University Okazaki Medical Center Hematology and Oncology Professor at the Hospital
  • 2019/04 - 2020/03 Fujita Health University Department of Hematology
  • 2018/10 - 2019/03 Fujita Health University Department of Hematology clinical professor
  • 2010/04 - 2018/10 Fujita Health University School of Medicine Department of Hematology and Medical Oncology Clinical professor
  • 2006/06 - 2013/03 Fujita Health University Hospital Outpatient Cancer Chemotherapy Center Chide
Show all
Committee career (7):
  • 2012/06 - 2024/06 日本リンパ網内系学会 COI委員会委員
  • 2011/04 - 2021/09 日本血液学会 造血器腫瘍診療ガイドライン委員
  • 2018/06 - 2020/06 日本リンパ網内系学会 プログラム委員会委員
  • 2016/06 - 2020/06 日本リンパ網内系学会 診療保険委員会委員
  • 2016/06 - 2020/06 日本リンパ網内系学会 理事
Show all
Association Membership(s) (7):
日本検査血液学会 ,  日本無菌生物ノートバイオロジー学会 ,  日本造血幹細胞移植学会 ,  日本臨床腫瘍学会 ,  日本血液学会 ,  日本内科学会 ,  日本リンパ網内系学会
※ Researcher’s information displayed in J-GLOBAL is based on the information registered in researchmap. For details, see here.

Return to Previous Page